Saturday, May 31, 2025
27.3 C
Bengaluru

Bring Your Own Learning

[wpfilebase tag=file id=76 tpl=download-button /]

Inside this Issue

1. Hire for Fire! by K. Hariram
A ‘fire in the belly’ (or hunger to succeed), is the most important quality needed for sales – the other skills can be taught.

2. ‘State of Flow’ and Peak Performance by Vivek Hattangadi
When competence meets challenge, ‘state of flow’ ensues – a mental state of high engagement with the task at hand, no matter how seemingly difficult.

3. A Sustainable Commercial Model for Indian Pharma by Hanno Wolfram
Part 2 of our Q&A with Hanno Wolfram.

4. DigiPharmaX 2016 by DigiPharmaX
Awarding Digital Excellence in Pharma. Nominations invited. Visit digipharmax.com

5. Satya Mahesh’s Must-Have Apps for the Tech-Enabled Medical Rep by Satya Mahesh
PART I in a list of must-have mobile apps in 12 categories from Learning and Development to Infotainment, curated by Satya Mahesh.

6. The Growing Concern with Household Medical Stockpiles by Ajesh Shah
In India, medicines are often not treated with the caution they deserve and pharmacies are both the cause and solution to the problem.

7. Measuring RoI of Marketing Spends Using Closed Loop Digital Marketing by Phanish Chandra
Closed Loop Digital Marketing for Pharma can help break the cycle of uncertainty over RoI from promotional activities to Doctors.

Hot this week

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?

Tata 1mg App Business Model: How does it work...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

Topics

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...
spot_img

Related Articles

spot_imgspot_img